Isocitrate Dehydrogenase 1 (IDH1) is a soluble, cytosolic enzyme involved in the TCA metabolic cycle. The most notable mutation in this enzyme, R132H, is clinically indicated in the majority of astrocytomas and oligodendroglial tumours, with the mutation being associated with more favourable prognosis and increased survival in those patients. IDH1 R132H is also useful in the differential diagnosis between anaplastic glioma and glioblastoma.

IDH1 R132H

  • Available Formats:

    0.1 ml Concentrate - IHC132-100

    1.0 ml Concentrate - IHC132-1

    7.0 ml Pre-Dilute - IHC132-7




    Source Mouse Monoclonal
    Positive Control Astrocytoma
    Dilution Range 1:50-1:200


    1. Cui D, et al. Int J Biochem Cell Biol. 2016;71:72-81.
    2. Balss J, et al. Acta Neuropathol. 2008; 116:597-602.
    3. Capper D, et al. Brain Pathol. 2010; 20:245-54.
    4. Camelo-Piragua S, et al. Acta Neuropathol. 2010; 119:509-11.

Follow Us

  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle

Subscribe to receive our latest promotions and updates

Contact Us

#1 - 3691 Viking Way

Richmond, BC V6V 2J6

[email protected]

[email protected]

[email protected]

(604) 244-9962

Copyright © 2019 GenomeMe